Innoprot will be participating in the one-on-one partnering in the next BIO International Convention, which will take place Boston, MA, from the 4th to 7th, June, 2017.
You can request a meeting with our delegate in the Convention, Mr. Jorge Gamiz, Business Development Director.
Innoprot will be showing our latest advances in GPCR screening, in vitro models to identify new drugs against Parkinson’s Disease, Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Stroke.
Innoprot Objectives:
Metabolic syndrome is characterized by dysregulated glucose metabolism and is
We are pleased to announce that Innoprot has been recognised
Acetyl-l-carnitine (ALC) is synthesized in the brain, liver, and kidneys
Neural stem cell (NSC) proliferation and differentiation in the mammalian
Allergic conjunctivitis (AC) is the most common form of allergic
The hepatic content of amyloid beta (Aβ) decreases drastically in